{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:50:34Z","timestamp":1790884234069,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014750","name":"San Pablo CEU University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010774","name":"Consejer\u00eda de Educaci\u00f3n e Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI2020\/01391"],"award-info":[{"award-number":["PI2020\/01391"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PT20\/00109"],"award-info":[{"award-number":["PT20\/00109"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","award":["CAM.IND2017\/BMD-7578"],"award-info":[{"award-number":["CAM.IND2017\/BMD-7578"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178146","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T15:47:23Z","timestamp":1758210443000},"page":"178146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Transcriptomic profiling unveils novel therapeutic options for drug-resistant temporal lobe epilepsy"],"prefix":"10.1016","volume":"1006","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7628-659X","authenticated-orcid":false,"given":"Patricia","family":"S\u00e1nchez-Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3493-718X","authenticated-orcid":false,"given":"Lola","family":"Alonso-Guirado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cerrada-G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Elizalde-Horcada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Granero-Cremades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Maietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6537-1468","authenticated-orcid":false,"given":"Antonio","family":"G\u00f3mez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6519-8885","authenticated-orcid":false,"given":"Francisco","family":"Abad-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Virginia","family":"Torres-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"de Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5722-2091","authenticated-orcid":false,"given":"Natalia","family":"Frade-Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gonzalez-Tarno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4082-5165","authenticated-orcid":false,"given":"Mar\u00eda C.","family":"Ovejero-Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178146_bib1","article-title":"Aprepitant's roles in abating seizures, behavioral, and cognitive deficits in mice model of epilepsy","volume":"159","author":"A Hassan","year":"2024","journal-title":"Epilepsy Behav. EB"},{"key":"10.1016\/j.ejphar.2025.178146_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/14737175.2020.1713100","article-title":"Avoiding complacency when treating uncontrolled seizures: why and how?","volume":"20","author":"Amin","year":"2020","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejphar.2025.178146_bib3","series-title":"Enhancing Drug Repurposing on Graphs by Integrating Drug Molecular Structure as Feature","first-page":"192","author":"Ayuso-Mu\u00f1oz","year":"2023"},{"key":"10.1016\/j.ejphar.2025.178146_bib4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/brainsci11050663","article-title":"Mechanisms of drug resistance in the pathogenesis of epilepsy: role of neuroinflammation. A literature review","volume":"11","author":"Bazhanova","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejphar.2025.178146_bib5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/acn3.364","article-title":"Staged anticonvulsant screening for chronic epilepsy","volume":"3","author":"Berdichevsky","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ejphar.2025.178146_bib6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.cellsig.2010.03.001","article-title":"The Src, Syk, and Tec family kinases: distinct types of molecular switches","volume":"22","author":"Bradshaw","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2025.178146_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acn3.703","article-title":"Drug repositioning in epilepsy reveals novel antiseizure candidates","volume":"6","author":"Brueggeman","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2025.178146_bib8","first-page":"S68","article-title":"Factors not considered in the study of drug-resistant epilepsy: drug-resistant epilepsy: assessment of neuroinflammation","volume":"7","author":"Campos-Bedolla","year":"2022","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.ejphar.2025.178146_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114144","article-title":"Prophylactic treatment with the c-Abl inhibitor, neurotinib, diminishes neuronal damage and the convulsive state in pilocarpine-induced mice","volume":"43","author":"Chand\u00eda-Cristi","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2025.178146_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107168","article-title":"Designing the 5HT2BR structure and its modulation as a therapeutic target for repurposing approach in drug-resistant epilepsy","volume":"194","author":"Chauhan","year":"2023","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2025.178146_bib11","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejphar.2025.178146_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178146_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178146_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygeno.2016.04.001","article-title":"RNA-seq analysis of hippocampal tissues reveals novel candidate genes for drug refractory epilepsy in patients with MTLE-HS","volume":"107","author":"Dixit","year":"2016","journal-title":"Genomics"},{"key":"10.1016\/j.ejphar.2025.178146_bib15","first-page":"1577","article-title":"MicroRNA-155 contributes to the occurrence of epilepsy through the PI3K\/Akt\/mTOR signaling pathway","volume":"42","author":"Duan","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2025.178146_bib16","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/s41467-024-46592-2","article-title":"Identification of gene regulatory networks affected across drug-resistant epilepsies","volume":"15","author":"Fran\u00e7ois","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.178146_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12859-023-05343-8","article-title":"Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing","volume":"24","author":"Garana","year":"2023","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ejphar.2025.178146_bib18","first-page":"5","article-title":"Use of oral antineoplastic in special situations in a third level hospital: real life results","volume":"42","author":"Garc\u00eda-Mu\u00f1oz","year":"2018","journal-title":"Farm. Hosp."},{"key":"10.1016\/j.ejphar.2025.178146_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1390105","article-title":"A comparative analysis of transcriptomics of newly diagnosed multiple myeloma: exploring drug repurposing","volume":"14","author":"Giannakoulas","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2025.178146_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/epi.13305","article-title":"Differential gene expression in dentate granule cells in mesial temporal lobe epilepsy with and without hippocampal sclerosis","volume":"57","author":"Griffin","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2025.178146_bib21","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/brain\/awz074","article-title":"Transcriptomic and genetic analyses reveal potential causal drivers for intractable partial epilepsy","volume":"142","author":"Guelfi","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2025.178146_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106671","article-title":"Computational drug repurposing by exploiting large-scale gene expression data: strategy, methods and applications","volume":"155","author":"He","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejphar.2025.178146_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bmt.1703383","article-title":"Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma","volume":"29","author":"Hequet","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejphar.2025.178146_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/wsbm.1337","article-title":"In silico methods for drug repurposing and pharmacology","volume":"8","author":"Hodos","year":"2016","journal-title":"WIREs Syst. Biol. Med."},{"key":"10.1016\/j.ejphar.2025.178146_bib25","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.43.12.2708","article-title":"A case of cerebral endometriosis causing catamenial epilepsy","volume":"43","author":"Ichida","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2025.178146_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.drudis.2012.07.014","article-title":"Transcriptional data: a new gateway to drug repositioning?","volume":"18","author":"Iorio","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2025.178146_bib27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.yebeh.2009.02.036","article-title":"Curing epilepsy: progress and future directions","volume":"14","author":"Jacobs","year":"2009","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejphar.2025.178146_bib28","doi-asserted-by":"crossref","first-page":"W411","DOI":"10.1093\/nar\/gkad412","article-title":"PanDrugs2: prioritizing cancer therapies using integrated individual multi-omics data","volume":"51","author":"Jim\u00e9nez-Santos","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.178146_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.5152\/balkanmedj.2015.15487","article-title":"Reversible posterior leukoencephalopathy syndrome due to carboplatin and paclitaxel therapy","volume":"32","author":"Kandemir","year":"2015","journal-title":"Balk. Med. J."},{"key":"10.1016\/j.ejphar.2025.178146_bib30","series-title":"Computational Methods for Drug Repurposing","first-page":"149","article-title":"An application of computational drug repurposing based on transcriptomic signatures","author":"Karatzas","year":"2019"},{"key":"10.1016\/j.ejphar.2025.178146_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awz265","article-title":"Transcriptome analysis in patients with temporal lobe epilepsy","volume":"142","author":"Kj\u00e6r","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2025.178146_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1528-1167.2011.03145.x","article-title":"The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis?","volume":"52","author":"Kobow","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2025.178146_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1684\/epd.2020.1143","article-title":"Epigenetics explained: a topic \u201cprimer\u201d for the epilepsy community by the ILAE Genetics\/Epigenetics Task Force","volume":"22","author":"Kobow","year":"2020","journal-title":"Epileptic Disord. Int. Epilepsy J. Videotape"},{"key":"10.1016\/j.ejphar.2025.178146_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655354","article-title":"Current and future therapeutic approaches for thymic stromal cell defects","volume":"12","author":"Kreins","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178146_bib35","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2025.178146_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/pharmaceutics13040545","article-title":"Drug repurposing for COVID-19 treatment by integrating network pharmacology and transcriptomics","volume":"13","author":"Liu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2025.178146_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.730257","article-title":"Single-target versus multi-target drugs versus combinations of drugs with multiple targets: preclinical and clinical evidence for the treatment or prevention of epilepsy","volume":"12","author":"L\u00f6scher","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178146_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs","volume":"20","author":"L\u00f6scher","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.ejphar.2025.178146_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020591","article-title":"Structural, molecular, and functional alterations of the blood-brain barrier during epileptogenesis and epilepsy: a cause, consequence, or both?","volume":"21","author":"L\u00f6scher","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178146_bib40","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2025.178146_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102207","article-title":"Epilepsy progression is associated with cumulative DNA methylation changes in inflammatory genes","volume":"209","author":"Martins-Ferreira","year":"2022","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.178146_bib42","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/cancers14030687","article-title":"Existing evidence for the repurposing of PARP-1 inhibitors in rare demyelinating diseases","volume":"14","author":"Mekhaeil","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2025.178146_bib43","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/brain\/awu373","article-title":"Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy","volume":"138","author":"Miller-Delaney","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2025.178146_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104612","article-title":"Coding and non-coding transcriptome of mesial temporal lobe epilepsy: critical role of small non-coding RNAs","volume":"134","author":"Mills","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2025.178146_bib45","first-page":"527","article-title":"Identifying new antiepileptic drugs through genomics-based drug repurposing","volume":"26","author":"Mirza","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2025.178146_bib46","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The support of human genetic evidence for approved drug indications","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2025.178146_bib47","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1159\/000539426","article-title":"Relationship between anaplastic lymphoma kinase inhibitors and epileptic seizure disorder: a post-marketing surveillance study","volume":"102","author":"Noguchi","year":"2024","journal-title":"Oncology"},{"key":"10.1016\/j.ejphar.2025.178146_bib48","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/acs.jcim.7b00721","article-title":"Searching for new leads to treat epilepsy: target-based virtual screening for the discovery of anticonvulsant agents","volume":"58","author":"Palestro","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejphar.2025.178146_bib49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s13311-014-0263-4","article-title":"Origins of temporal lobe epilepsy: febrile seizures and febrile status epilepticus","volume":"11","author":"Patterson","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejphar.2025.178146_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14650-z","article-title":"Cross platform analysis of transcriptomic data identifies ageing has distinct and opposite effects on tendon in males and females","volume":"7","author":"Pease","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178146_bib51","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/nprot.2016.095","article-title":"Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown","volume":"11","author":"Pertea","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2025.178146_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/epi.12452","article-title":"Optimizing antiepileptic drug treatment in tumoral epilepsy","volume":"54","author":"Perucca","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2025.178146_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13028","article-title":"Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women","volume":"34","author":"Reddy","year":"2022","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2025.178146_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fncel.2013.00115","article-title":"Role of hormones and neurosteroids in epileptogenesis","volume":"7","author":"Reddy","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178146_bib55","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178146_bib56","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/s12035-022-03180-z","article-title":"DNA methylation description of Hippocampus, Cortex, Amygdala, and blood of drug-resistant temporal lobe epilepsy","volume":"60","author":"S\u00e1nchez-Jim\u00e9nez","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.178146_bib57","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.3390\/ijms22105351","article-title":"Beneficial effects of metformin on the central nervous system, with a focus on epilepsy and lafora disease","volume":"22","author":"Sanz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178146_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.796","article-title":"Enteral lorlatinib after alectinib as a treatment option in anaplastic lymphoma kinase-positive non-small cell lung cancer with triple problems: carcinomatous meningitis, poor performance status, and dysphagia\u2014a case report","volume":"9","author":"Sasaki","year":"2021","journal-title":"Respirol. Case Rep."},{"key":"10.1016\/j.ejphar.2025.178146_bib59","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1528-1167.2005.54904.x","article-title":"Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms","volume":"46","author":"Schmidt","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2025.178146_bib60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/14728222.2024.2343952","article-title":"Role of non-receptor tyrosine kinases in epilepsy: significance and potential as therapeutic targets","volume":"28","author":"Shanker","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2025.178146_bib61","first-page":"4","article-title":"[Pharmacoresistant temporal-lobe epilepsy. Exploration with foramen ovale electrodes and surgical outcomes]","volume":"41","author":"Sola","year":"2005","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.ejphar.2025.178146_bib62","article-title":"Computational prediction of frequent hitters in target-based and cell-based assays","volume":"1","author":"Stork","year":"2021","journal-title":"Artif. Intell. Life Sci."},{"key":"10.1016\/j.ejphar.2025.178146_bib63","first-page":"3793","article-title":"Integrating transcriptomic and structural insights: revealing drug repurposing opportunities for sporadic ALS","volume":"9","author":"Sunildutt","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejphar.2025.178146_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577802","article-title":"The TLR4 mediated inflammatory signal pathway might be involved in drug resistance in drug-resistant epileptic rats","volume":"365","author":"Tang","year":"2022","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2025.178146_bib65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.seizure.2015.02.012","article-title":"Interactions between hormones and epilepsy","volume":"28","author":"Taub\u00f8ll","year":"2015","journal-title":"Seizure Gender Issues Epilepsy"},{"key":"10.1016\/j.ejphar.2025.178146_bib66","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14737175.2020.1707668","article-title":"The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection","volume":"20","author":"Verrotti","year":"2020","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejphar.2025.178146_bib67","doi-asserted-by":"crossref","first-page":"868","DOI":"10.4161\/hv.28400","article-title":"Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches","volume":"10","author":"Vitaliti","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ejphar.2025.178146_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.110109","article-title":"Drug repurposing in status epilepticus","volume":"161","author":"Walker","year":"2024","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejphar.2025.178146_bib69","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/WNR.0b013e32826fb3a5","article-title":"Poly(ADP-ribose) polymerase inhibitor is neuroprotective in epileptic rat via apoptosis-inducing factor and Akt signaling","volume":"18","author":"Wang","year":"2007","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2025.178146_bib70","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s11011-022-00909-6","article-title":"The role of Rho\/ROCK in epileptic seizure-related neuronal damage","volume":"37","author":"Wang","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2025.178146_bib71","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s40262-015-0267-1","article-title":"Impact of genetic polymorphisms of ABCB1 (MDR1, P-glycoprotein) on drug disposition and potential clinical implications: update of the literature","volume":"54","author":"Wolking","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2025.178146_bib72","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fneur.2013.00192","article-title":"Clinical pharmacology and pharmacokinetics of levetiracetam","volume":"4","author":"Wright","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejphar.2025.178146_bib73","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.7150\/ijbs.24612","article-title":"Review of drug repositioning approaches and Resources","volume":"14","author":"Xue","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2025.178146_bib74","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuroscience.2012.11.009","article-title":"Poly(ADP-ribose) polymerase inhibition protects epileptic hippocampal neurons from apoptosis via suppressing Akt-mediated apoptosis-inducing factor translocation in vitro","volume":"231","author":"Yang","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2025.178146_bib75","article-title":"Drug repositioning for diabetes based on \u201comics\u201d data mining","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.178146_bib76","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12264-019-00437-x","article-title":"Role of elevated thrombospondin-1 in kainic acid-induced status epilepticus","volume":"36","author":"Zhang","year":"2020","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ejphar.2025.178146_bib77","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad142","article-title":"Decoding Connectivity Map-based drug repurposing for oncotherapy","volume":"24","author":"Zhao","year":"2023","journal-title":"Brief. Bioinform."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:30:11Z","timestamp":1780201811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925009008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":77,"alternative-id":["S0014299925009008"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178146","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptomic profiling unveils novel therapeutic options for drug-resistant temporal lobe epilepsy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178146"}}